Stem Cell Clinics Face Long Odds Against FDA in Legal Fight

August 6, 2018

(Bloomberg) – Two stem cell clinic operators may be facing tough odds in a legal fight with the FDA to stay in business. The Food and Drug Administration made a big splash in May when it took the stem cell clinic operators to court in California and Florida, seeking to shut them down for offering unapproved treatments the agency says are potentially dangerous. The FDA says the stem cell treatments produced by the clinics are drug products and therefore under the agency’s purview.

Recommended Reading